Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%
Portfolio Pulse from Benzinga Neuro
Investment analysts have upgraded price targets for six stocks, including four U.S.-listed companies: Shift4 Payments Inc (FOUR), Semtech Corp (SMTC), Formula One Group, and MacroGenics Inc (MGNX), with MacroGenics expected to see an 82% surge due to positive trial data. Despite market volatility, these upgrades suggest potential investment opportunities.
April 05, 2024 | 6:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Shift4 Payments received a buy recommendation despite a recent 15% drop, with potential benefits from a $30 billion Visa and MasterCard settlement.
The buy recommendation and potential benefits from the Visa and MasterCard settlement could drive investor interest and stock price recovery.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
MacroGenics Inc sees an 82% price target surge due to positive trial data for its vobra-duo drug, indicating significant upside potential.
The significant price target upgrade following positive trial data suggests strong confidence in MacroGenics' future performance, likely attracting investor interest.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 90
POSITIVE IMPACT
Semtech Corp is among the U.S.-listed companies with upgraded price targets, indicating potential short-term gains.
Price target upgrades generally lead to increased investor interest and can positively impact stock prices in the short term.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70